Elan chairman Robert Ingram at the company’s EGM in Dublin today. Photograph: Aidan Crawley

Elan shareholders decisively rejected a major investment programme proposed by the company at a special meeting in Dublin today.However, investors nar(...)

Elan chief executive Kelly Martin: the firm faces a critical moment in its volatile history with tomorrow’s EGM.

Irish biotech group Elan has been through many critical moments in its volatile history. Tomorrow, shareholders gather for an extraordinary general me(...)

Elan chairman Robert Ingram. In a statement to the Irish Stock Exchange, Elan said it was “proceeding with a formal sale process”. Photograph: David Sleator

Irish biotech group Elan has put itself on the market after indications that shareholders will reject key elements of its restructuring plan.In a stat(...)